Zobrazeno 1 - 10
of 9 091
pro vyhledávání: '"Hardin, M."'
Autor:
Lugogo NL, Heffler E, Plaza V, Hilberg O, Xia C, Nash S, Pandit N, Jacob-Nara JA, Sacks HJ, Rowe PJ, Deniz Y, Hardin M, Soler X
Publikováno v:
Journal of Asthma and Allergy, Vol Volume 17, Pp 551-556 (2024)
Nijra L Lugogo,1 Enrico Heffler,2,3 Vicente Plaza,4 Ole Hilberg,5 Changming Xia,6 Scott Nash,6 Nami Pandit,7 Juby A Jacob-Nara,7 Harry J Sacks,6 Paul J Rowe,7 Yamo Deniz,6 Megan Hardin,8 Xavier Soler6 1University of Michigan Medical School, Ann Arbor
Externí odkaz:
https://doaj.org/article/64ff62dd9ebb439e9492f73c12d942d8
Autor:
Maspero JF, Bachert C, Martinez FJ, Hanania NA, Ortiz B, Patel N, Mannent LP, Praestgaard A, Pandit-Abid N, Siddiqui S, Hardin M
Publikováno v:
Journal of Asthma and Allergy, Vol Volume 16, Pp 333-342 (2023)
Jorge F Maspero,1 Claus Bachert,2,3 Fernando J Martinez,4 Nicola A Hanania,5 Benjamin Ortiz,6 Naimish Patel,7 Leda P Mannent,8 Amy Praestgaard,7 Nami Pandit-Abid,9 Shahid Siddiqui,6 Megan Hardin7 1Allergy and Respiratory Research Unit, Fundación CID
Externí odkaz:
https://doaj.org/article/d9b11e05ce4e45f983c0ad0e3accd5ce
Autor:
Maspero JF; Fundación CIDEA, Buenos Aires, Argentina. Electronic address: jorge.maspero@fundacioncidea.org.ar., Antila MA; Clínica de Alergía, Sorocaba, Sao Paulo, Brazil., Deschildre A; University Lille, CHU Lille, Pediatric Pulmonology and Allergy Department, Hôpital Jeanne de Flandre, 59000 Lille, France., Bacharier LB; Division of Allergy, Immunology and Pulmonary Medicine, Monroe Carell Jr Children's Hospital at Vanderbilt University Medical Center, Nashville, Tenn., Altincatal A; Sanofi, Cambridge, Mass., Laws E; Sanofi, Bridgewater, NJ., Mortensen E; Regeneron Pharmaceuticals Inc., Tarrytown, NY., Radwan A; Regeneron Pharmaceuticals Inc., Tarrytown, NY., Jacob-Nara JA; Sanofi, Bridgewater, NJ., Deniz Y; Regeneron Pharmaceuticals Inc., Tarrytown, NY., Rowe PJ; Sanofi, Bridgewater, NJ., Lederer DJ; Regeneron Pharmaceuticals Inc., Tarrytown, NY., Hardin M; Sanofi, Cambridge, Mass.
Publikováno v:
The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2024 Aug 27. Date of Electronic Publication: 2024 Aug 27.
Dupilumab improves pediatric type 2 asthma outcomes independent of patient baseline characteristics.
Autor:
Maspero JF; Fundación CIDEA, Buenos Aires, Argentina. Electronic address: jorge.maspero@fundacioncidea.org.ar., Fiocchi AG; Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Deschildre A; Pediatric Pulmonology and Allergy Department, CHU Lille, Hôpital Jeanne de Flandre, Université de Lille, Lille, France., Bacharier LB; Division of Allergy, Immunology and Pulmonary Medicine, Monroe Carell Jr. Children's Hospital at Vanderbilt University Medical Center, Nashville, Tenn., Altincatal A; Sanofi, Cambridge, Mass., Laws E; Sanofi, Bridgewater, NJ., Lederer DJ; Regeneron Pharmaceuticals Inc., Tarrytown, New York, NY., Akinlade B; Regeneron Pharmaceuticals Inc., Tarrytown, New York, NY., Hardin M; Sanofi, Cambridge, Mass.
Publikováno v:
The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2024 Aug 08. Date of Electronic Publication: 2024 Aug 08.
Autor:
Bacharier LB; Monroe Carell Jr Children's Hospital at Vanderbilt University Medical Center, Nashville, Tenn. Electronic address: leonard.bacharier@vumc.org., Pavord ID; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom., Maspero JF; Fundación CIDEA, Buenos Aires, Argentina., Jackson DJ; University of Wisconsin School of Medicine and Public Health, Madison, Wis., Fiocchi AG; Bambino Gesù Children's Hospital IRCCS, Rome, Italy., Mao X; Sanofi, Bridgewater, NJ., Jacob-Nara JA; Sanofi, Bridgewater, NJ., Deniz Y; Regeneron Pharmaceuticals Inc, Tarrytown, NY., Laws E; Sanofi, Bridgewater, NJ., Mannent LP; Sanofi, Chilly-Mazarin, France., Amin N; Sanofi, Bridgewater, NJ., Akinlade B; Sanofi, Bridgewater, NJ., Staudinger HW; Sanofi, Bridgewater, NJ., Lederer DJ; Regeneron Pharmaceuticals Inc, Tarrytown, NY., Hardin M; Sanofi, Cambridge, Mass.
Publikováno v:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2024 Jul; Vol. 154 (1), pp. 101-110. Date of Electronic Publication: 2024 Jan 23.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pavord ID; National Institute for Health Care and Research Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom., De Prado Gómez L; Sanofi, Madrid, Spain., Brusselle G; Ghent University Hospital, Ghent, Belgium., Jackson DJ; University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin., Brightling CE; University of Leicester, Leicester, United Kingdom., Papi A; Respiratory Medicine Unit, University of Ferrara, S. Anna University Hospital, Ferrara, Italy., Maspero JF; Fundación CIDEA, Buenos Aires, Argentina., Rabe KF; LungenClinic Grosshansdorf and.; Christian-Albrechts University (members of the German Center for Lung Research), Airway Research Center North, Grosshansdorf, Germany., Korn S; IKF Pneumologie Mainz and Thoraxklinik Heidelberg, Heidelberg, Germany., Zhang M; Sanofi, Bridgewater, New Jersey., Soler X; Regeneron Pharmaceuticals Inc., Tarrytown, New York; and., Jacob-Nara JA; Sanofi, Bridgewater, New Jersey., Hardin M; Sanofi, Cambridge, Massachusetts.
Publikováno v:
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2024 Apr 15; Vol. 209 (8), pp. 1031-1033.
Autor:
Maspero JF; Fundación CIDEA, Buenos Aires, Argentina. Electronic address: jorge.maspero@fundacioncidea.org.ar., Peters AT; Northwestern University Feinberg School of Medicine, Chicago, Ill., Chapman KR; University of Toronto, Toronto, ON, Canada., Domingo C; Corporació Sanitària Parc Taulí, Sabadell, Autonomous University of Barcelona, Barcelona, Spain., Stewart J; Sanofi, Montreal, QC, Canada., Hardin M; Sanofi, Cambridge, Mass., Maroni J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY., Tawo K; Sanofi, Bridgewater, NJ., Khokhar FA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY., Mortensen E; Regeneron Pharmaceuticals, Inc., Tarrytown, NY., Laws E; Sanofi, Bridgewater, NJ., Radwan A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY., Jacob-Nara JA; Sanofi, Bridgewater, NJ., Deniz Y; Regeneron Pharmaceuticals, Inc., Tarrytown, NY., Rowe PJ; Sanofi, Bridgewater, NJ.
Publikováno v:
The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2024 Apr; Vol. 12 (4), pp. 991-997.e6. Date of Electronic Publication: 2023 Dec 30.
Autor:
Bacharier LB; Division of Allergy, Immunology and Pulmonary Medicine, Monroe Carell Jr Children's Hospital at Vanderbilt University Medical Center, Nashville, Tenn. Electronic address: leonard.bacharier@vumc.org., Guilbert TW; Cincinnati Children's Hospital and University of Cincinnati, Cincinnati, Ohio., Katelaris CH; Campbelltown Hospital, Campbelltown, NSW, Australia; Western Sydney University, Sydney, NSW, Australia., Deschildre A; CHU Lille, Lille University Hospital, Lille, France; Pediatric Pulmonology and Allergy Department, Hôpital Jeanne de Flandre Hospital, Lille, France., Phipatanakul W; Department of Allergy and Immunology, Boston Children's Hospital, Boston, Mass; Department of Pediatrics, Harvard Medical School, Boston, Mass., Liu D; Department of Immunology, Sanofi, Beijing, China., Altincatal A; Department of Immunology, Sanofi, Cambridge, Mass., Mannent LP; Department of Immunology, Sanofi, Gentilly, France., Amin N; Department of Medical Affairs, Regeneron Pharmaceuticals Inc., Tarrytown, NY., Laws E; Department of Immunology, Sanofi, Bridgewater, NJ., Akinlade B; Department of Medical Affairs, Regeneron Pharmaceuticals Inc., Tarrytown, NY., Jacob-Nara JA; Department of Medical Affairs, Regeneron Pharmaceuticals Inc., Tarrytown, NY., Deniz Y; Department of Medical Affairs, Regeneron Pharmaceuticals Inc., Tarrytown, NY., Rowe PJ; Department of Immunology, Sanofi, Bridgewater, NJ., Lederer DJ; Department of Medical Affairs, Regeneron Pharmaceuticals Inc., Tarrytown, NY., Hardin M; Department of Immunology, Sanofi, Cambridge, Mass.
Publikováno v:
The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2024 Apr; Vol. 12 (4), pp. 948-959. Date of Electronic Publication: 2023 Dec 11.
Real-world effectiveness of dupilumab in patients with asthma: Findings from the US ADVANTAGE study.
Autor:
Blaiss M; Medical College of Georgia at Augusta University, Augusta, Georgia. Electronic address: michael.blaiss@gmail.com., Bleecker ER; University of Arizona College of Medicine, Tucson, Arizona., Jacob-Nara J; Sanofi, Bridgewater, New Jersey., Nair R; Sanofi, Cambridge, Massachusetts., Duh MS; Analysis Group, Inc, Boston, Massachusetts., Wang Z; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Stanford RH; AESARA Inc, Chapel Hill, North Carolina., Soler X; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Hardin M; Sanofi, Cambridge, Massachusetts., Ye M; Analysis Group, Inc, Boston, Massachusetts., Khanal A; Analysis Group, Inc, Boston, Massachusetts., Borsos K; Sanofi, Cambridge, Massachusetts.
Publikováno v:
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2024 Apr; Vol. 132 (4), pp. 463-468.e1. Date of Electronic Publication: 2023 Nov 14.